The fallout for Venture Global Inc., in the wake of a troubled initial public offering, accelerated amid a market selloff ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Even so the deal solidifies Venture Global’s place in the public markets with an impressive $50 billion market cap. And it ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

The U.S. IPO market is moving forward with a steady flow of applicants. Investors this week are awaiting the U.S. Fed's ...

The IPO trend remains robust in 2025, driven by strong retail investor interest and a shift from FPIs to the primary market.

Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

The GLP-1 IPO arena has been heating up for the past two years and Metsera’s ask is one the largest in recent history.

Domestic investors will be reacting to Q3 results from several companies, including Tata Steel, Bajaj Housing Finance, Coal ...

Denta Water and Infra IPO Allotment Status, GMP, Price Band, Listing Date Live Updates: Check Denta Water IPO allotment ...